Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for Proposal relating to provisional agreement with API Consumer Brands Limited for the listings of various pharmaceuticals. Closed , browse documents here.


29 October 2009

Proposal relating to provisional agreement with API Consumer Brands Limited for the listings of various pharmaceuticals on the Pharmaceutical Schedule

PHARMAC is seeking feedback on a proposal involving cholecalciferol (Cal-d-Forte), codeine phosphate (PSM), dexamphetamine sulphate (PSM), glycerol (PSM), isoniazid (PSM), paracetamol (Paracare), pethidine hydrochloride (PSM) and phenobarbitone (PSM) through a provisional agreement with API Consumer Brands. If implemented, the proposal would result in various subsidy and price changes for the above pharmaceuticals, which API Consumer Brands already supplies.

Feedback sought PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by 5 pm on Thursday 12 November 2009 to: Mike Bignall Therapeutic Group Manager PHARMAC Email: mike.bignall@pharmac.govt.nz Fax: 04 460 4995 Post: PO Box 10 254, Wellington 6143

All feedback received before the closing date will be considered by PHARMAC’s Board (or Chief Executive acting under delegated authority) prior to making a decision on this proposal.

Details of the proposal · The following pharmaceuticals would be amended in Section B and amended (or listed, where applicable) in Part II of Section H of the Pharmaceutical Schedule from 1 January 2010 as follows:

Form and Strength Tab 1.25 mg (50,000 iu) Tab 15 mg Codeine phosphate Dexamphetamine sulphate Tab 30 mg Tab 60 mg Tab 5 mg PSM 100 PSM 100 Pack size 12 Current price and subsidy $10.35 $5.50 $8.50 $18.50 $17.00 Proposed price and subsidy $7.76 $5.39 $8.25 $17.76 $16.50

Chemical

Brand Cal-dForte

Cholecalciferol

A264370 Page 1 of 2


Chemical Glycerol Isoniazid Paracetamol Pethidine hydrochloride Phenobarbitone

Form and Strength Suppos 3.6 g Tab 100 mg Suppos 500 mg Tab 50 mg Tab 100 mg Tab 15 mg Tab 30 mg

Brand PSM PSM Paracare PSM

Pack size 20 100 50 10

Current price and subsidy $5.00 $20.50 $20.50 $3.00 $4.00 $23.68 $24.59

Proposed price and subsidy $6.00 $20.00 $20.50 $3.20 $4.20 $25.00 $26.00

PSM

500

Prices are ex-manufacturer, excluding GST

·

All brands listed above of these pharmaceuticals would have subsidy and delisting protection until 31 December 2012.

Background information This proposal is a result of API Consumer Brands submitting to PHARMAC an alternative commercial proposal to tendering. A request for alternative commercial proposals was made to all pharmaceutical suppliers on 21 August 2009 as part of the consultation on the proposed 2009/10 Multi-product Tender.

A264370 Page 2 of 2

Metadata

Title

Proposal relating to provisional agreement with API Consumer Brands Limited for the listings of various pharmaceuticals. Closed

Abstract

29 October 2009 Proposal relating to provisional agreement with API Consumer Brands Limited for the listings of various pharmaceuticals on the Pharmaceutical Schedule PHARMAC is seeking feedback on a proposal involving cholecalciferol (Cal-d-Forte), codeine phosphate (PSM), dexamphetamine sulphate (PSM), glycerol…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.